Biomerica logo

BiomericaNASDAQ: BMRA

Profile

Sector:

Healthcare

Country:

United States

IPO:

07 September 1984

Next earnings report:

16 January 2025

Last dividends:

N/A

Next dividends:

N/A
$6.38 M
-89%vs. 3y high
14%vs. sector
-vs. 3y high
-vs. sector
-83%vs. 3y high
45%vs. sector
-86%vs. 3y high
25%vs. sector

Price

regular market | 14 min ago
$0.38+$0.02(+4.20%)

Dividend

No data over the past 3 years
$1.81 M-$1.32 M

Analysts recommendations

Institutional Ownership

BMRA Latest News

Biomerica Reports First Quarter Fiscal 2025 Financial Results
globenewswire.com16 October 2024 Sentiment: POSITIVE

IRVINE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the first quarter of fiscal 2025 ended August 31, 2024.

The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer
globenewswire.com04 September 2024 Sentiment: POSITIVE

- 10-Minute At-Home PSA Test for Early Detection of Prostate Cancer - First order already shipped to Saudi Arabia - Prostate Cancer is the Second Most Common Cancer in Men Globally IRVINE, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) is pleased to announce that the Saudi Food and Drug Authority (SFDA) has approved the Company's Fortel® Prostate (PSA) Screening Test to be sold and used in the country.

Biomerica Reports Fiscal 2024 Year End Results
globenewswire.com29 August 2024 Sentiment: POSITIVE

IRVINE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) today reported its financial results for the fiscal year ended May 31, 2024. The Company achieved a modest increase in net sales to $5.4 million, compared to $5.3 million in the prior year. This growth was primarily driven by strong demand for EZ Detect™ colorectal screening tests and Aware® breast self-exam products in the Middle East including the United Arab Emirates.

Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers
globenewswire.com01 July 2024 Sentiment: POSITIVE

IRVINE, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, is proud to announce a major enhancement to its inFoods® IBS system, aimed at simplifying and transforming the patient experience.

What type of business is Biomerica?

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops, markets, and sells COVID-19 diagnostic tests to indicate if a person has been infected by COVID-19. The company was incorporated in 1971 and is headquartered in Irvine, California.

What sector is Biomerica in?

Biomerica is in the Healthcare sector

What industry is Biomerica in?

Biomerica is in the Medical Devices industry

What country is Biomerica from?

Biomerica is headquartered in United States

When did Biomerica go public?

Biomerica initial public offering (IPO) was on 07 September 1984

What is Biomerica website?

https://www.biomerica.com

Is Biomerica in the S&P 500?

No, Biomerica is not included in the S&P 500 index

Is Biomerica in the NASDAQ 100?

No, Biomerica is not included in the NASDAQ 100 index

Is Biomerica in the Dow Jones?

No, Biomerica is not included in the Dow Jones index

When was Biomerica the previous earnings report?

No data

When does Biomerica earnings report?

The next expected earnings date for Biomerica is 16 January 2025